Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
British Journal of Cancer|November 1, 1992
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130)S Dessí, B Batetta, C Anchisi, et al.Current Cancer Drug Targets|June 11, 2009
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing miceA Bonetto, F Penna, V G Minero, et al.Cancer Letters|May 4, 1995
Enhanced leucine oxidation in rats bearing an ascites hepatoma (Yoshida AH-130) and its reversal by clenbuterolP Costelli, M Llovera, C García-Martínez, et al.Cancer Letters|August 16, 1995
Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130)P Costelli, M Llovera, N Carbó, et al.Biochemical Pharmacology|November 6, 2008
Mechanisms of clofibrate-induced apoptosis in Yoshida AH-130 hepatoma cellsF Penna, P Reffo, G Muzio, et al.Chemico-Biological Interactions|January 1, 1989
Effect of two aliphatic aldehydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130L Tessitore, G Bonelli, P Costelli, et al.Cephalalgia : an International Journal of Headache|June 1, 1994
Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraineG Murialdo, S Fonzi, P Costelli, et al.Cell Death & Disease|April 19, 2014
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagyS Gallo, S Gatti, V Sala, et al.The Journal of Nutrition|March 20, 1999
Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulinP Costelli, L Tessitore, B Batetta, et al.Cancer Letters|January 19, 1996
Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486M Llovera, C García-Martínez, P Costelli, et al.Pageof 6